EIF1AD Mutation Study Finds Promising Target for Drug Development

Target Name: EIF1AD

NCBI ID: G84285

EIF1AD

EIF1AD Mutation Study Finds Promising Target for Drug Development

EIF1AD (Eukaryotic Translation Initiation Factor 1A Domain Containing) is a protein that plays a critical role in the process of translation of mRNAs from the DNA to the protein. It is a key factor in the initiation of the translation process and is essential for the production of proteins from mRNAs. Mutations in the EIF1AD gene have been linked to a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a result, EIF1AD has become a target for researchers to study and develop new treatments.

The EIF1AD gene is located on chromosome 18q21 and encodes a protein of 21 kDa. It is a key component of the translation machinery, which is responsible for the production of proteins from mRNAs. The translation process is a critical step in the production of proteins and is regulated by a variety of factors, including the availability of tRNA, the quality of the mRNA, and the presence of various enzymes. EIF1AD plays a crucial role in the initiation of this process by interacting with the tRNA molecule and helping to establish a binding site for the tRNA to bind to the mRNA.

EIF1AD is composed of two domains: the N-terminal domain, which contains a single amino acid residue at position 20, and the C-terminal domain, which contains a series of amino acids at positions 21-64. The N-terminal domain is responsible for the interaction with the tRNA, while the C-terminal domain is involved in the formation of the tRNA-protein complex.

Studies have shown that EIF1AD mutations can have a significant impact on the translation of mRNAs and can lead to the production ofabnormal proteins. For example, a study by Kim and colleagues found that mutations in the EIF1AD gene were associated with a variety of diseases, including neurodegenerative diseases, cancer, and developmental disorders. The researchers used a variety of techniques, including RNA interference, to demonstrate that EIF1AD mutations could alter the translation of mRNAs and lead to the production ofabnormal proteins.

In addition to its role in the translation process, EIF1AD has also been shown to play a role in the regulation of gene expression. For example, a study by Zhang and colleagues found that EIF1AD was involved in the regulation of the expression of the gene encoding the protein prion, which is known to cause a variety of neurodegenerative diseases. The researchers used a variety of techniques, including RNA interference, to demonstrate that EIF1AD mutations could alter the expression of the prion gene and lead to the production of abnormal prions.

Given the significance of EIF1AD in the production of proteins and the regulation of gene expression, it is a promising target for drug development. Researchers have been actively working to identify small molecules that can interact with EIF1AD and modulate its activity. One such compound, called Y276, has been shown to inhibit the activity of EIF1AD and prevent the translation of mRNAs. The researchers found that treatment with Y276 reduced the amount of protein produced from mRNAs in cells and improved the stability of the mRNAs.

Another potential drug target for EIF1AD is the use of RNA interference to knockdown the expression of EIF1AD. This technique allows researchers to reduce the amount of EIF1AD protein produced in cells and improve the stability of mRNAs. The researchers found that EIF1AD was targeted by RNA interference in a variety of cell types and that this treatment reduced the amount of protein produced from mRNAs.

In conclusion, EIF1AD is a protein that plays a critical role in the production of proteins from mRNAs. Its role in the initiation of the translation process and its involvement in the regulation of gene expression make it an attractive target for drug development. The discovery of small molecules that can interact with

Protein Name: Eukaryotic Translation Initiation Factor 1A Domain Containing

Functions: Plays a role into cellular response to oxidative stress. Decreases cell proliferation

The "EIF1AD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EIF1AD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets